What is Regeneron Pharmaceuticals Inc's Market Cap?

Regeneron Pharmaceuticals Inc's Market Cap is $83.4B, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's Enterprise Value?

Regeneron Pharmaceuticals Inc's Enterprise Value is $78.1B, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's Trailing P/E?

Regeneron Pharmaceuticals Inc's Trailing P/E is 19.3×, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's Price / Sales?

Regeneron Pharmaceuticals Inc's Price / Sales is 5.4×, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's EV / Revenue?

Regeneron Pharmaceuticals Inc's EV / Revenue is 5.0×, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's EV / EBITDA?

Regeneron Pharmaceuticals Inc's EV / EBITDA is 17.9×, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's Revenue (TTM)?

Regeneron Pharmaceuticals Inc's Revenue (TTM) is $15.5B, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's Net Income (TTM)?

Regeneron Pharmaceuticals Inc's Net Income (TTM) is $4.3B, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's EBITDA?

Regeneron Pharmaceuticals Inc's EBITDA is $4.4B, based on as-reported figures from SEC (XBRL) filings.

What is Regeneron Pharmaceuticals Inc's Diluted EPS (TTM)?

Regeneron Pharmaceuticals Inc's Diluted EPS (TTM) is 42.04, based on as-reported figures from SEC (XBRL) filings.

Regeneron Pharmaceuticals Inc (REGN) Financial Statements

Regeneron Pharmaceuticals Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S6PX49

XNAS · usd

810.31▼ 17.41 (-2.10%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close827.72

Day's Range799.42 – 821.17

52-Week Range541.00 – 859.34

Volume552.1K

Avg Volume688.0K

Share Statistics

Shares Outstanding

Employees15.4K

ExchangeXNAS

Listed1991-04-02

Share count as of July 23, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Regeneron Pharmaceuticals Inc (REGN)

What is Regeneron Pharmaceuticals Inc's Market Cap?: Regeneron Pharmaceuticals Inc's Market Cap is $83.4B, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's Enterprise Value?: Regeneron Pharmaceuticals Inc's Enterprise Value is $78.1B, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's Trailing P/E?: Regeneron Pharmaceuticals Inc's Trailing P/E is 19.3×, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's Price / Sales?: Regeneron Pharmaceuticals Inc's Price / Sales is 5.4×, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's EV / Revenue?: Regeneron Pharmaceuticals Inc's EV / Revenue is 5.0×, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's EV / EBITDA?: Regeneron Pharmaceuticals Inc's EV / EBITDA is 17.9×, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's Revenue (TTM)?: Regeneron Pharmaceuticals Inc's Revenue (TTM) is $15.5B, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's Net Income (TTM)?: Regeneron Pharmaceuticals Inc's Net Income (TTM) is $4.3B, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's EBITDA?: Regeneron Pharmaceuticals Inc's EBITDA is $4.4B, based on as-reported figures from SEC (XBRL) filings.
What is Regeneron Pharmaceuticals Inc's Diluted EPS (TTM)?: Regeneron Pharmaceuticals Inc's Diluted EPS (TTM) is 42.04, based on as-reported figures from SEC (XBRL) filings.